News & Media

News

Mar 31, 2020

Covid-19 (Coronavirus): Immunosuppressive treatments in dermatology

Last updated: 3rd April 2020

The British Association of Dermatologists (BAD) is aware of the concerns about Covid-19 of people who are taking medicines that affect the immune system such as biologic therapies and/or immunosuppressants. 

Immunosuppressants and medication Frequently Asked Questions (FAQs)
Information for dermatology patients

St. John’s Institute of Dermatology at Guy’s and St Thomas’ hospital in London has developed a set of FAQs about immunosuppressive treatments in general so that patients can better understand their risks. The FAQs cover a range of common questions including those on shielding, social distancing, decision making on continuing or stopping treatment and much more.

These can be found on the Guy’s website: https://www.guysandstthomas.nhs.uk/our-services/dermatology/dermatology-and-coronavirus-frequently-asked-questions.aspx#na – scroll down to “Immunosuppressants and medication”.

NHS England FAQ on shielding for patients

The NHSE FAQ on shielding for patients is available here: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/20200401-FAQs-Patients.pdf

Risk stratification grid for healthcare professionals

The BAD has provided a grid for healthcare professionals which will help them to identify patients for whom, due to their disease and treatment, Covid-19 poses a higher risk. The grid can be viewed here: http://www.bad.org.uk/healthcare-professionals/covid-19/covid-19-immunosuppressed-patients

This will help to guide decision making, however decisions will always be made on an individual basis depending upon your specific circumstances.